Cancer SocietyMonday 20 February 2012, 5:04PM
Chief Executive of the Cancer Society, Dalton Kelly, today
challenged stakeholders at a PHARMAC forum whether the time hasn't
come to abandon the silo approach to delivery of disease prevention
and treatment, as is apparent in the public sector.
"Our worry has long been the silo approach where different health
groups and divisions get on with their objectives and roles -
whether it be buying drugs or running a public health promotion.
But I wonder whether the revolution in technologies, and the
understanding of the holistic approach, shouldn't be leading us to
think about the spectrum as a whole. Dalton Kelly had a work of
praise for the country's drug purchasing agency.
"PHARMAC, along with its siblings that deal with vaccines, Maori
health, smoking cessation and so on, has worked well for New
Zealand. Until relatively recently PHARMAC had to deal with a
dwindling allocation of funds, while on the other hand new and very
expensive drugs became available.
"The paradigm has shifted further. New blockbuster drugs are
increasingly few and far between. And while these drugs come at an
enormous cost, I have two comments. The first is 'thank
goodness we still have researchers looking for new cures and
resolutions, and secondly the cancer community does understand how
much R&D trials, particularly failed trials, cost in a
commercial world.
"And anecdotally, we find that many of our acceptable day to day
drugs, like aspirin, would never have made it through today's
rigorous testing as the side effects, such as bleeding, would have
been regarded as unacceptable."
In closing Dalton noted that one of the reasons he had raised the
issue of the silo mentality was because, "being based in Wellington
I hear a lot about the 'joined-up government approach for many
policy issues, ranging from infrastructure development to delivery
of welfare services. But this-joined up idea still has to
come to fruition in the health sector. I know efforts are being
made, but suggest we need to do better.
"It is not just deciding what drugs will or won't be funded,
whether provincial cities continue to retain maternity services or
if breakfast will be served at low decile schools - somehow we need
to get a hand on the big picture, the helicopter approach, which
draws all these threads together.
"A great example just this is the work currently being done to
enhance the Cancer Registry. This is a great initiative that will
capture information about every one of the 20,000 cancer cases
diagnosed every year. The work enhances the existing registry
and will ultimately provide a brilliant planning tool so that DHBs
will really know if trends indicate they need new equipment,
staffing and resources, it will allow researchers and clinicians to
know what treatments have been applied and what outcomes have
occurred."